SLAMF1 anticorps (AA 296-325)

N° du produit ABIN358048

Détail du produit anti-SLAMF1 anticorps

Antigène: SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))

Épitope: AA 296-325

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SLAMF1 est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificité: This antibody detects CD150/SLAMF1.

Purification: Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogène: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 296~325 amino acids surrounding Y307 of Human SLAMF1.

Isotype: Ig Fraction

Information d'application

Indications d'application: ELISA: 1/1,000. Western Blot: 1/50-1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) Sodium Azide as preservative.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.

Détails sur SLAMF1

Antigène: SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))

Autre désignation: CD150 / SLAMF1 (SLAMF1 Produits)

Synonymes: anticorps CD150, anticorps SLAM, anticorps SLAMF1, anticorps 4933415F16, anticorps AA177906, anticorps CDw150, anticorps ESTM51, anticorps IPO-3, anticorps Slam, anticorps RGD1560634, anticorps signaling lymphocytic activation molecule family member 1, anticorps SLAMF1, anticorps Slamf1

Sujet: SLAMF1 is high-affinity self-ligand important in bidirectional T-cell to B-cell stimulation. SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates.Synonyms: CDw150, Ipo-3, Signaling lymphocytic activation molecule, Slam

Poids moléculaire: 37231 Da

ID gène: 6504, 9606

UniProt: Q13291